萬控智造(603070.SH):主要產品和主要收入來源未發生變化
格隆匯1月9日丨萬控智造(603070.SH)公佈,公司股票價格短期內升幅較大,近三個交易日累計升幅達33.06%,且最近一個交易日換手率達51.45%,公司股票交易量和換手率相較以往出現大幅增長。公司股票的最新市盈率為34.26、最新滾動市盈率為61.11,大幅高於行業市盈率水平。
公司當前從事配電開關控制設備業務,主要產品為高低壓電氣機櫃、環網櫃設備、氣體絕緣開關櫃設備等,主要產品和主要收入來源未發生變化。受宏觀經濟形勢和下游行業有效需求不足等因素影響,公司2024年前三季度營業收入和淨利潤出現下滑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.